BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 29689097)

  • 1. Characterization of Transglutaminase 2 activity inhibitors in monocytes in vitro and their effect in a mouse model for multiple sclerosis.
    Chrobok NL; Bol JGJM; Jongenelen CA; Brevé JJP; El Alaoui S; Wilhelmus MMM; Drukarch B; van Dam AM
    PLoS One; 2018; 13(4):e0196433. PubMed ID: 29689097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue Transglutaminase contributes to experimental multiple sclerosis pathogenesis and clinical outcome by promoting macrophage migration.
    van Strien ME; de Vries HE; Chrobok NL; Bol JGJM; Breve JJP; van der Pol SMP; Kooij G; van Buul JD; Karpuj M; Steinman L; Wilhelmus MM; Sestito C; Drukarch B; Van Dam AM
    Brain Behav Immun; 2015 Nov; 50():141-154. PubMed ID: 26133787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monocyte behaviour and tissue transglutaminase expression during experimental autoimmune encephalomyelitis in transgenic CX3CR1
    Chrobok NL; Jaouen A; Fenrich KK; Bol JG; Wilhelmus MM; Drukarch B; Debarbieux F; van Dam AM
    Amino Acids; 2017 Mar; 49(3):643-658. PubMed ID: 27826792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue transglutaminase in marmoset experimental multiple sclerosis: discrepancy between white and grey matter.
    Espitia Pinzon N; Stroo E; 't Hart BA; Bol JG; Drukarch B; Bauer J; van Dam AM
    PLoS One; 2014; 9(6):e100574. PubMed ID: 24959868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transglutaminase 2 exacerbates experimental autoimmune encephalomyelitis through positive regulation of encephalitogenic T cell differentiation and inflammation.
    Oh K; Park HB; Seo MW; Byoun OJ; Lee DS
    Clin Immunol; 2012 Nov; 145(2):122-32. PubMed ID: 23001131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel extracellular role for tissue transglutaminase in matrix-bound VEGF-mediated angiogenesis.
    Wang Z; Perez M; Caja S; Melino G; Johnson TS; Lindfors K; Griffin M
    Cell Death Dis; 2013 Sep; 4(9):e808. PubMed ID: 24052076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy.
    Yuan L; Siegel M; Choi K; Khosla C; Miller CR; Jackson EN; Piwnica-Worms D; Rich KM
    Oncogene; 2007 Apr; 26(18):2563-73. PubMed ID: 17099729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Progress in the Development of Transglutaminase 2 (TGase2) Inhibitors.
    Song M; Hwang H; Im CY; Kim SY
    J Med Chem; 2017 Jan; 60(2):554-567. PubMed ID: 28122456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuronal and Endothelial Transglutaminase-2 Expression during Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.
    Pearse DD; Otero PA; Diaz A; Pan X; Ghosh M
    Neuroscience; 2021 May; 461():140-154. PubMed ID: 33253822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Potent and Selective Tissue Transglutaminase Inhibitors: Their Effect on TG2 Function and Application in Pathological Conditions.
    Badarau E; Wang Z; Rathbone DL; Costanzi A; Thibault T; Murdoch CE; El Alaoui S; Bartkeviciute M; Griffin M
    Chem Biol; 2015 Oct; 22(10):1347-61. PubMed ID: 26456735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monocyte-derived tissue transglutaminase in multiple sclerosis patients: reflecting an anti-inflammatory status and function of the cells?
    Sestito C; Brevé JJP; van Eggermond MCJA; Killestein J; Teunissen CE; van Rossum J; Wilhelmus MMM; Drukarch B; van den Elsen PJ; van Dam AM
    J Neuroinflammation; 2017 Dec; 14(1):257. PubMed ID: 29268771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic inhibition of the enzymatic effects of tissue transglutaminase reduces cardiac fibrosis and attenuates cardiomyocyte hypertrophy following pressure overload.
    Shinde AV; Su Y; Palanski BA; Fujikura K; Garcia MJ; Frangogiannis NG
    J Mol Cell Cardiol; 2018 Apr; 117():36-48. PubMed ID: 29481819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation and inhibition of transglutaminase 2 in mice.
    Dafik L; Albertelli M; Stamnaes J; Sollid LM; Khosla C
    PLoS One; 2012; 7(2):e30642. PubMed ID: 22319575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Appearance of tissue transglutaminase in astrocytes in multiple sclerosis lesions: a role in cell adhesion and migration?
    van Strien ME; Drukarch B; Bol JG; van der Valk P; van Horssen J; Gerritsen WH; Breve JJ; van Dam AM
    Brain Pathol; 2011 Jan; 21(1):44-54. PubMed ID: 20731658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting ovarian tumor cell adhesion mediated by tissue transglutaminase.
    Khanna M; Chelladurai B; Gavini A; Li L; Shao M; Courtney D; Turchi JJ; Matei D; Meroueh S
    Mol Cancer Ther; 2011 Apr; 10(4):626-36. PubMed ID: 21330459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of potent and specific dihydroisoxazole inhibitors of human transglutaminase 2.
    Klöck C; Herrera Z; Albertelli M; Khosla C
    J Med Chem; 2014 Nov; 57(21):9042-64. PubMed ID: 25333388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astrocyte-derived tissue Transglutaminase affects fibronectin deposition, but not aggregation, during cuprizone-induced demyelination.
    Espitia Pinzon N; Sanz-Morello B; Brevé JJ; Bol JG; Drukarch B; Bauer J; Baron W; van Dam AM
    Sci Rep; 2017 Jan; 7():40995. PubMed ID: 28128219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of TG2-inhibitory monoclonal antibody zampilimab on tissue fibrosis in human in vitro and primate in vivo models of chronic kidney disease.
    Huang L; Bon H; Maamra M; Holmes T; Atkinson J; Cain K; Kennedy J; Kettleborough C; Matthews D; Twomey B; Ni J; Song Z; Watson PF; Johnson TS
    PLoS One; 2024; 19(5):e0298864. PubMed ID: 38753630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue Transglutaminase-Mediated AT1 Receptor Sensitization Underlies Pro-inflammatory Cytokine LIGHT-Induced Hypertension.
    Liu C; Luo R; Wang W; Peng Z; Johnson GVW; Kellems RE; Xia Y
    Am J Hypertens; 2019 Apr; 32(5):476-485. PubMed ID: 30715101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acylideneoxoindoles: a new class of reversible inhibitors of human transglutaminase 2.
    Klöck C; Jin X; Choi K; Khosla C; Madrid PB; Spencer A; Raimundo BC; Boardman P; Lanza G; Griffin JH
    Bioorg Med Chem Lett; 2011 May; 21(9):2692-6. PubMed ID: 21215619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.